Idexx Laboratories Private Limited - Due diligence report

A 360° intelligence report on Idexx Laboratories: trust score, financial health, credit view, compliance, directors, growth and distress sig…

2016-11-17 Bangalore, Karnataka Active Unlisted Active Compliant
Share
Connect MCP
IL Idexx Laboratories Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Idexx Laboratories — 360° Intelligence Report

Generated from MCA filings & public records
92/100
Trust Score
Low Risk

Idexx Laboratories is assessed as Low Risk with a Trust Score of 92/100. Idexx Laboratories is an active private limited foreign company incorporated in india incorporated in 2016, operating in the Healthcare sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.

Report generated on 14 Aug 2026 from the latest processed filings. Idexx Laboratories Private Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
92/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
100/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
90/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
60/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
90/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
80/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 60/100 Moderate
  • Liabilities ≈ 38% EBITDA - stretched.
  • No open charges - unencumbered balance sheet.
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 100/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
JEFFERY DONN CHADBOURNE 01234567 Director 01/04/2018 6 yrs Approved
WILLARD R BLANCHE JR 01234567 Director 01/04/2018 6 yrs Approved
NILESH CHANDRAKANTH SHAH 01234567 Director 01/04/2018 6 yrs Approved
LILY JOANN LU 01234567 Director 01/04/2018 6 yrs Approved
Ellen Adelaide Arrigoni 01234567 Director 01/04/2018 6 yrs Approved
  • 5 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
Idexx B.v.
Subsidiaries
-
Group entities
-
Capital events
4 allotment(s) · 0 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Group entityRelationship% held
Idexx B.v. Holding Company 74.00%

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 90 · Distress 80
Growth signals & trust indicators
Revenue acceleration: +1.42 over 4 year(s).
Profit expanded 2.1x year-on-year.
Asset base grew 24% - capacity expansion.
Net margin improved to 0.86.
Operating for 9 years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Outside liabilities up 61% in a year.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence92/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment79/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view90/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 4 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
03 Nov 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
30 Oct 2024
Director appointed
Ellen Adelaide Arrigoni (Director)
10 Mar 2020
Securities allotted
5500000 Equity Shares - 5.50 cr raised
30 Sep 2019
Director ceased
LILY JOANN LU
10 Jun 2019
Securities allotted
2090000 Equity Shares - 2.09 cr raised
01 May 2019
Director ceased
BRIAN PATRICK MC KEON
22 Feb 2019
Director appointed
LILY JOANN LU (Director)
29 Sep 2018
Director ceased
JEFFERY DONN CHADBOURNE
Director ceased
WILLARD R BLANCHE JR
21 Jun 2018
Director ceased
STEVEN MORRIS
30 Apr 2018
Director ceased
JOHN ROYAL MORTON
28 Apr 2018
Director appointed
JEFFERY DONN CHADBOURNE (Director)
Director appointed
WILLARD R BLANCHE JR (Director)
31 Dec 2017
Director ceased
MRINAL KUMAR SHARMA
10

Key Observations

Auto-generated from the data above
Revenue grew 38% over the last 4 financial year(s).
Net profit margin moved from 1.42 to 2.1x.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
5 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
Capital has been raised through 4 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Reelabs U85100MH2009PTC190531 Mumbai, Maharashtra, India
Manaltheeram Ayurvedic Hospital And Research Centre Private Limited U85110KL2000PTC013758 Thiruvananthapuram, Kerala, India
Mediheal Healthcare Private Limited U85300MP2021PTC056037 Indore, Madhya Pradesh, India
Baby Joy Ivf Centre U85100DL2013PTC252643 New Delhi, Delhi, India
Optimum Therapeutics Private Limited U85100DL2011PTC228675 New Delhi, Delhi, India
Momentum Orthopaedic Private Limited U85110WB2011PTC160959 Kolkata, West Bengal, India
Chirayu Health And Medicare Pvt Ltd U50110MP1995PTC009315 Bhopal, Madhya Pradesh, India
Nazarbad Medical Services Private Limited U85110KA1990PTC010912 Mysore, Karnataka, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Idexx Laboratories before audits and certifications: compliance score 100/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Idexx Laboratories: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 60/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 90/100, margin trends, ownership structure and peer set for Idexx Laboratories - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 92/100, distress signals and MSME payment-delay disclosures - know whether Idexx Laboratories pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Idexx Laboratories - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Idexx Laboratories an active company?

Idexx Laboratories has MCA status “Active” with a compliance score of 100/100 (Low Risk).

Is Idexx Laboratories financially healthy?

Idexx Laboratories has a Financial Health Score of 90/100 (Low Risk) based on its filed financial statements.

Should I do business with Idexx Laboratories?

Its overall Trust Score is 92/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Idexx Laboratories?

The ultimate holding entity is Idexx B.v.. 5 active director(s) are on record.

Does Idexx Laboratories have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Idexx Laboratories up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 100/100 (Low Risk).

Is it risky to lend to Idexx Laboratories?

Its Credit Risk Score is 60/100 (Moderate). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.